期刊文献+

仝小林院士辨治新型冠状病毒肺炎——“寒湿疫”辨治体系的形成、创新与发展 被引量:35

Syndrome Differentiation and Treatment of COVID-19 by Academician Tong Xiaolin:Origin,Innovation,and Development of“Cold-Dampness Plague”Theory
下载PDF
导出
摘要 2019年末至2020年初,武汉地区暴发新型冠状病毒肺炎,仝小林院士在一线抗疫60余日。在此期间,他提出和制定了诸多学术观点和实践方案:1)创“三维定性”之法,并依此而将武汉新冠疫情定性为“寒湿疫”。2)针对“寒湿疫”早期,制宣肺化湿之法,并依此开具寒湿疫方,对疫情进行早期截断。3)创“武昌模式”高效有序推行寒湿疫方,将防控重心下沉前移至社区。4)针对“寒湿疫”重症期,发现“瘀热入营”是转重之关键病机,并制定了系列治法。5)针对“寒湿疫”恢复期,提出从“虚、毒、瘀”去辨治的临床策略,并依此制定了恢复期通治方。6)从“分期—分证”的角度,结合“治未病”理论,将“寒湿疫”分为“四期十六证”,建立了相对完善的“寒湿疫”辨治体系。 From the end of 2019 to the beginning of 2020,Wuhan experienced the epidemic of COVID-19,and Academician Tong Xiaolin fought against the epidemic for more than 60 days.During this period,he put forward many academic viewpoints and practical plans,which are listed below.1)He identified COVID-19 as“cold-dampness plague”based on the“three-dimensional qualitative”method.2)For the early-stage patients,he formulated the formulas targeting the“cold-dampness plague”(Hanshiyi Formulas for short)by ventilating lung and resolving dampness to cut off the epidemic at an early stage.3)He created the“Wuchang Pattern”to efficiently carry out Hanshiyi Formulas,and shifted the focus of prevention and control to the communities.4)For the patients at the critical stage,he discovered that“stagnant heat entering nutrient-blood”was the key pathogenesis of the exacerbation,and formulated a series of treatment methods.5)For the patients at the convalescent stage,he proposed a clinical strategy of syndrome differentiation and treatment from“deficiency,toxin,and blood stasis”,and formulated a general formula for the recovery period accordingly.6)From the perspective of“staging-syndrome differentiation”,he divided the“cold-dampness plague”into four stages and 16 syndromes based on the theory of“treating disease before its onset”,and established a complete system of differentiation and treatment of“cold-dampness plague”.
作者 杨映映 李青伟 鲍婷婷 宋斌 雷烨 高泽正 沈仕伟 王强 赵林华 仝小林 YANG Yingying;LI Qingwei;BAO Tingting;SONG Bin;LEI Ye;GAO Zezheng;SHEN Shiwei;WANG Qiang;ZHAO Linhua;TONG Xiaolin(Guang′anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,China;Beijing University of Chinese Medicine,Beijing 100029,China;The Third Affiliated Hospital of Zunyi Medical University,Zunyi 563002,China;The Second Affiliated Hospital of Shaanxi University of Chinese Medicine,Xianyang 712000,China;Human Phenome Institute,Fudan University,Shanghai 200433,China;Northeast International Hospital,Shenyang 110623,China)
出处 《世界中医药》 CAS 2022年第6期833-837,842,共6页 World Chinese Medicine
基金 国家重点研发计划“公共安全风险防控与应急技术装备”重点专项(2020YFC0845000)——新冠肺炎恢复期中医药干预的临床评价研究。
关键词 新型冠状病毒肺炎 中医药 寒湿疫 三维定性 寒湿疫方 辨治体系 仝小林 COVID-19 Traditional Chinese medicine Cold-dampness plague Three-dimensional qualitative method Hanshiyi Formulas Syndrome differentiation and treatment system Tong Xiaolin
  • 相关文献

参考文献8

二级参考文献30

共引文献871

同被引文献329

引证文献35

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部